284
Participants
Start Date
November 30, 2010
Primary Completion Date
December 31, 2012
Study Completion Date
December 31, 2012
GE-145
GE-145-320 mg I/mL as a single iv. administration. Comparator agent Isovue (iopamidol) 370 mg I/mL as a single iv. administration.
GE Healthcare, Princeton
Lead Sponsor
Collaborators (2)
i3 Statprobe
INDUSTRY
Medpace, Inc.
INDUSTRY
Biomedical Systems
INDUSTRY
Rules-Based Medicine, Inc.
INDUSTRY
GE Healthcare
INDUSTRY